Health & Biotech

The Pot Seat: Botanix’s Matt Callahan says synthetics are the future of cannabis drugs

February 19, 2019February 19, 2019 | Rachel Williamson

Health & Biotech

Weed week: In Canada pot is hot; in Australia it’s just a steady glow

February 7, 2019February 7, 2019 | Rachel Williamson

Health & Biotech

If pot is so hot, why aren’t cannabis directors buying their own companies?

February 6, 2019February 6, 2019 | Rachel Williamson

Health & Biotech

Profitable pot stock Elixinol is getting excited about US growth opportunities

January 31, 2019January 31, 2019 | Sam Jacobs

Health & Biotech

Nearly every country in the world is better at pot than Australia: Elixinol boss

January 24, 2019January 23, 2019 | Daniel Paproth

News

Lunchtime ASX small cap wrap: who deserves an award today?

January 23, 2019 | Daniel Paproth

Health & Biotech

Another Aussie pot stock has just crossed the Tasman thanks to new NZ weed laws

January 23, 2019 | Daniel Paproth

Health & Biotech

Weed week: America says no to munchies

January 10, 2019January 11, 2019 | Rachel Williamson

IPO Watch

IPOs of 2018: The few that floated when most didn’t

December 21, 2018February 9, 2019 | Rachel Williamson

Health & Biotech

US Congress has two weeks left to vote on legalising hemp farming

December 11, 2018December 11, 2018 | Rachel Williamson

Health & Biotech

Weed week: wtf happened with MMJ?

November 22, 2018February 9, 2019 | Rachel Williamson

Health & Biotech

Weed week: here’s all the news driving the cannabis market (including hemp gin)

November 8, 2018November 8, 2018 | Rachel Williamson